HUTCHISON CHINA/S (HCM) Receives Average Recommendation of “Buy” from Analysts

HUTCHISON CHINA/S (NASDAQ:HCM) has been given an average recommendation of “Buy” by the six research firms that are covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a hold recommendation, three have given a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year price target among analysts that have covered the stock in the last year is $26.82.

HCM has been the topic of several research analyst reports. BidaskClub downgraded HUTCHISON CHINA/S from a “buy” rating to a “hold” rating in a research note on Saturday, December 22nd. Zacks Investment Research upgraded HUTCHISON CHINA/S from a “sell” rating to a “hold” rating in a research note on Wednesday, December 26th. ValuEngine downgraded HUTCHISON CHINA/S from a “buy” rating to a “hold” rating in a research note on Wednesday, January 2nd. Finally, Deutsche Bank initiated coverage on HUTCHISON CHINA/S in a research note on Monday, March 4th. They set a “buy” rating and a $26.82 price target on the stock.

HUTCHISON CHINA/S stock traded down $0.16 during trading hours on Friday, hitting $30.35. 136,296 shares of the stock traded hands, compared to its average volume of 126,689. The company has a debt-to-equity ratio of 0.06, a quick ratio of 4.19 and a current ratio of 4.33. The company has a market cap of $4.05 billion, a PE ratio of -53.25 and a beta of 1.11. HUTCHISON CHINA/S has a 1 year low of $20.83 and a 1 year high of $39.68.

Several institutional investors and hedge funds have recently modified their holdings of the company. Gulf International Bank UK Ltd boosted its stake in shares of HUTCHISON CHINA/S by 433.3% in the first quarter. Gulf International Bank UK Ltd now owns 16,000 shares of the company’s stock worth $489,000 after buying an additional 13,000 shares during the last quarter. Deutsche Bank AG boosted its stake in shares of HUTCHISON CHINA/S by 300.9% in the fourth quarter. Deutsche Bank AG now owns 129,822 shares of the company’s stock worth $2,995,000 after buying an additional 97,440 shares during the last quarter. Geode Capital Management LLC raised its holdings in HUTCHISON CHINA/S by 639.3% in the 4th quarter. Geode Capital Management LLC now owns 114,934 shares of the company’s stock worth $2,636,000 after purchasing an additional 99,388 shares during the period. Macquarie Group Ltd. acquired a new position in HUTCHISON CHINA/S in the 4th quarter worth about $46,000. Finally, Legal & General Group Plc acquired a new position in HUTCHISON CHINA/S in the 4th quarter worth about $4,082,000. Hedge funds and other institutional investors own 16.57% of the company’s stock.

HUTCHISON CHINA/S Company Profile

Hutchison China MediTech Limited, a commercial-stage biopharmaceutical company, engages in discovery, development, and commercialization of targeted therapeutics and immunotherapies for oncology and immunological diseases in the People's Republic of China and Hong Kong. The company operates through Innovation Platform and Commercial Platform segments.

Recommended Story: What does cost of debt say about a company’s financial health?

Receive News & Ratings for HUTCHISON CHINA/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HUTCHISON CHINA/S and related companies with MarketBeat.com's FREE daily email newsletter.